日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE

在JADE DARE研究中，对接受度普利尤单抗治疗的中重度特应性皮炎患者进行事后疗效分析，探讨从度普利尤单抗转换为阿布昔替尼治疗的疗效。

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01320-y
Silverberg, Jonathan I; Simpson, Eric L; Pink, Andrew E; Weidinger, Stephan; Chan, Gary; Biswas, Pinaki; Clibborn, Claire; Güler, Erman
发表日期：2025
文献求助 收藏

A Report and Proposals for Future Activity from the Inaugural Artificial Intelligence in Dermatology Symposium Held at the International Societies for Investigative Dermatology 2023 Meeting

2023年国际皮肤病学研究学会年会期间举办的首届皮肤病学人工智能研讨会报告及未来活动建议

期刊:JID Innovations
影响因子:
doi:10.1016/j.xjidi.2023.100236
Wongvibulsin, Shannon; Sangers, Tobias; Clibborn, Claire; Li, Yu-Chuan Jack; Sharma, Nikhil; Common, John E A; Reynolds, Nick J; Tanaka, Reiko J
发表日期：2024
文献求助 收藏

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

在 3 期 JADE COMPARE 研究中，阿布昔替尼治疗中重度特应性皮炎患者各身体部位症状/体征改善速度

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-022-00694-1
Alexis, Andrew; de Bruin-Weller, Marjolein; Weidinger, Stephan; Soong, Weily; Barbarot, Sebastien; Ionita, Ileana; Zhang, Fan; Valdez, Hernan; Clibborn, Claire; Yin, Natalie
OMP
COMP
OMPA
发表日期：2022
文献求助 收藏

Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics

特应性皮炎瘙痒和疼痛的分子和细胞机制及其对新型疗法的启示

期刊:Clinical & Translational Immunology
影响因子:3.8
doi:10.1002/cti2.1390
Kwatra, Shawn G; Misery, Laurent; Clibborn, Claire; Steinhoff, Martin
细胞生物学
发表日期：2022
文献求助 收藏